Arkolith/Insider Trading/LXRX/Form 4

Debbane Raymond

DirectorLEXICON PHARMACEUTICALS, INC. (LXRX) · full profile →Form 4 · filed Feb 23, 2026
Net Buying
Open-Market Buys
$220K
Open-Market Sells
$0
Net Open-Market Flow
$220K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 20, 2026Buy(P)100K$1.48$148K1.8M
Feb 19, 2026Buy(P)50K$1.44$72K1.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062822-26-000031) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML